BDBM50169896 3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[1,3,5]triazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::CHEMBL363590

SMILES OCCCNc1cncc(c1)-c1ncnc(Nc2ccc3OCCOc3c2)n1

InChI Key InChIKey=NDADSQVDVRXBPR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50169896   

TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50169896(3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[...)
Affinity DataIC50:  4.14E+3nMAssay Description:Inhibition of vascular endothelial growth factor receptor 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50169896(3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[...)
Affinity DataIC50:  344nMAssay Description:Inhibition of cyclin dependent kinase (CDK1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed